Transforming Cardiac Care

Women’s Heart Health: Uncovering Hidden Risks with AI-QCT

Webinar with Live Q&A — February 19, 2026, 7 pm ET

How AI plaque analysis supports sex-specific health insights

In Cleerly’s fourteenth Transforming Cardiac Care webinar, preventative cardiologist Dr. Suzanne Steinbaum presents the latest research on women’s cardiovascular risk, disease presentation, and treatment outcomes.

The session will explore critical sex-based differences in cardiovascular disease, highlighting how these variations impact diagnosis and clinical decision-making. Dr. Steinbaum will showcase how AI-enabled quantitative coronary CT (AI-QCT) improves diagnostic accuracy and risk stratification for all patients, regardless of sex. Through real-world case studies, attendees will gain practical insights into how advanced imaging and data-driven approaches can support more personalized, equitable cardiovascular care.

Attendees will also learn about emerging research from the CONFIRM2 registry, one of the few registries in which about 50% of the participants are female. With a diverse trial population of 3,500 participants from sites across 11 countries, this research highlights the generalized applicability of AI-QCT in addressing cardiovascular health disparities.

Dr. Steinbaum’s presentation will conclude with a Q&A session, open to all attendees.

Our Key Panelists

Dr. Suzanne Steinbaum
Preventive Cardiologist, CEO and Founder of Adesso

Dr. Suzanne Steinbaum is a leader in preventive cardiology, now in private practice in New York City. She is the CEO and Founder of Adesso, a clinical software solution for women's cardiovascular prevention, health, and wellness. She was the director of Women's Heart Health programs at Mt. Sinai Heart, Northwell Lenox Hill, and Beth Israel. She published Dr. Suzanne Steinbaum’s Heart Book: Every Woman’s Guide to a Heart Healthy Life, and has been a national spokesperson for the American Heart Association's Go Red for Women program for over 20 years.

Michelle Gearhart, PharmD
VP Medical Affairs, Cleerly

Michelle is an experienced Medical Affairs and Scientific Affairs leader, with over two decades of experience at prominent organizations, including Johnson & Johnson and Esperion. She is a passionate advocate for women’s health, and currently leads the Medical Affairs team at Cleerly.

February 19, 2026 @ 7 pm ET

Register now:

You will receive an email confirmation with access information.

Discussion Topics

Sex-Specific Disease Risk

Recognizing variations in symptom presentation and outcomes improves heart disease diagnosis and treatment strategies for women.

Diagnostic Limitations

Women’s cardiac risk may be underestimated by traditional diagnostic methods, but AI-QCT can serve as an accurate approach for both sexes.

The Role of Plaque

AI-QCT allows for precise plaque characterization and quantification, which is critical for heart disease risk stratification in women.

Equity through Data

Cleerly’s AI-QCT analysis can help democratize care by using diverse population datasets to quantify disease burden.

Cleerly's Transforming Cardiac Care webinar series is open to any cardiologist, radiologist, or other healthcare professional with an interest in breakthrough medtech for heart disease and prevention.